Annual data report on surgical treatment of esophageal cancer in Shanghai Chest Hospital in 2015
- VernacularTitle:2015 年上海市胸科医院食管癌外科治疗数据报告
- Author:
Xufeng GUO
1
;
Haoyao JIANG
1
;
Rong HUA
1
;
Bin LI
1
;
Xiaobin ZHANG
1
;
Yifeng SUN
1
;
Zhigang LI
1
Author Information
1. Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, P.R.China
- Publication Type:Journal Article
- Keywords:
Esophageal cancer;
esophagectomy;
multidisciplinary treatment
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2020;27(09):1070-1074
- CountryChina
- Language:Chinese
-
Abstract:
Objective To give an annual data report of surgical treatment of esophageal cancer in Shanghai Chest Hospital to provide reference for treatment and research on esophageal cancer. Methods The clinical data of 414 patients with esophageal cancer who underwent endoscopy (9 patients) and esophagectomy (405 patients) in Shanghai Chest Hospital in 2015 were reviewed, including 334 males and 80 females. Their tumor biological characteristics and short-term and long-term treatment results were analyzed. Results Patients in this group were predominantly aged 60 to 69 years (46.9%), and the tumor was mainly located in the middle thorax (50.7%). About 79.9% of the patients received trans-right thoracic esophagectomy, 44.4% received minimally invasive surgery; 388 (93.7%) patients accepted upfront esophagectomy without induction therapy, and 179 (43.2%) patients received postoperative adjuvant therapy. The R0 resection rate was 90.6%, and the 30- and 90-day mortality rates were 1.4% and 2.4%, respectively. The 4-year overall survival rate of the R0 resection patients was 65.7%. Conclusion Satisfactory long-term survival results can be obtained for thoracic esophageal cancer if R0 resection can be achieved by trans-right thoracic esophagectomy and extended lymphadenectomy combined with appropriate postoperative adjuvant treatment.
